Open Accessibility Menu

Coronavirus (COVID-19) Update - We are open with your safety in mind. Click here to learn more.

For information about COVID-19, the vaccine, or to view additional resources, please click here.

  • Certified ALS Center Program
    Certified ALS Center Program
  • Level 4 Epilepsy Center - national association of epilepsy centers
    National Association of Epilepsy Centers
  • Comprehensive Stroke Center
  • AANEM EDX Lab Accreditation - exemplary status
    AANEM EDX Lab Accreditation

Clinical Research

Washington DC Headache Center

The GW Medical Faculty Associates Headache Center is dedicated to advancing our knowledge and understanding of headache disorders. Our primary research goal is to develop new and improved treatments that are effective and safe for patients suffering from headaches. To accomplish this we initiate our own projects and also participate in clinical research on the local, national and international levels. Please see below for brief descriptions of our active research projects.

  • Single center study evaluating the effect of intensive education on clinical outcome, patient satisfaction and direct medical costs in the migraine patient population
  • Multicenter national trial investigating the safety and clinical effectiveness of an experimental calcitonin-gene related peptide (CGRP) antagonist for the preventive treatment of migraine
  • Single center study investigating the clinical effectiveness and cost savings associated with implementation of a clinic–based "headache rescue room”
  • A phase 4 randomized controlled study to evaluate the efficacy and safety of erenumab in adults with medication overuse headaches
  • A 12 month study comparing sustained benefit of two treatment paradigms (erenumab monthly versus oral preventive medication) in adult episodic migraine patients

If you would like to learn more about our research or even potentially participate as a patient in one of our studies, contact our Headache Research Center at:

Phone: (202) 677-6210

Conveniently Located

Clinical Trials

  • INSYTE: Management of Parkinson’s Disease Psychosis in Actual Practice (The INSYTE Study)
    The INSYTE Study will examine the current disease progression of Parkinson’s disease Psychosis (PDP), the clinical, economic, and humanistic impact of anti-psychotic therapy in the management of the condition in real-world settings, and the burden of the condition on patients and their caregivers.
  • Protocol H8H-MC-LAIJ, Randomized Controlled Trial of Lasmiditan Over Four Migraine Attacks
    The objective of this Phase 3 study is to evaluate the efficacy of lasmiditan 200 mg and 100 mg on migraine headache pain freedom compared to placebo.